Comac Medical is pleased to announce our participation in the 17th Annual Outsourcing in Clinical Trials (OCT) New England 2025, taking place on October 15–16, 2025, in Boston, Massachusetts, USA. This leading event for clinical operations professionals in the region brings together senior-level decision-makers, service providers, and industry experts to discuss strategies for optimizing clinical trials and advancing outsourcing partnerships. 

Representing Comac Medical at this year’s conference are Chris Lancaster, Senior Business Development Director, and Christian Buhlmann, Chief Commercial Officer. Together, they will be engaging with industry professionals, exploring new collaborations, and highlighting how Comac Medical’s full-service CRO expertise supports efficient and reliable clinical development. 

The agenda will feature dedicated tracks and sessions on clinical operations & outsourcing, clinical technology & innovation, patient recruitment & engagement, and rare disease trials. Attendees can expect practical case studies, expert panels, and valuable networking opportunities designed to tackle today’s most pressing challenges in clinical research. 

Join Chris and Christian at OCT New England 2025 to explore opportunities for collaboration and learn more about Comac Medical’s comprehensive clinical research solutions.